GA 0113

Drug Profile

GA 0113

Latest Information Update: 23 Feb 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Asahi Glass; Mitsubishi Pharma Corporation
  • Class Heart failure therapies
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension

Most Recent Events

  • 23 Feb 2004 Discontinued - Preclinical for Hypertension in Japan (PO)
  • 06 May 2003 Preclinical trials in Hypertension in Japan (PO)
  • 06 Apr 2000 Yoshitomi is now called Welfide Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top